Aegerion Pharmaceuticals Company Profile (NASDAQ:AEGR)

About Aegerion Pharmaceuticals

Aegerion Pharmaceuticals logoAegerion Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the development and commercialization of therapies for patients with debilitating rare diseases. It operates through pharmaceuticals segment. Its products include lomitapide and metreleptin. Lomitapide is a small molecule microsomal triglyceride transfer protein (MTP) inhibitor. Lomitapide received marketing approval under the brand name Juxtapid (lomitapide) capsules from the United States Food and Drug Administration (FDA) as an adjunct to a low-fat diet and other lipid-lowering treatments. It also received marketing authorization for lomitapide in the European Union (EU) under the brand name LOJUXTA (lomitapide) hard capsules (LOJUXTA) as a treatment for HoFH in adults. Metreleptin is a recombinant human leptin analog that exerts its function by binding to and activating the human leptin receptor. Metreleptin is marketed in the United States under the brand name MYALEPT (metreleptin) for injection (MYALEPT).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: AEGR
  • CUSIP: 00767E10
Key Metrics:
  • Previous Close: $0.00
  • 50 Day Moving Average: $1.93
  • 200 Day Moving Average: $1.81
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -4.35
  • P/E Growth: -0.04
  • Market Cap: $N/A
  • Beta: 0.5
Profitability:
  • Net Margins: -106.62%
  • Return on Equity: -287.49%
  • Return on Assets: -30.75%
Debt:
  • Debt-to-Equity Ratio: -19.22%
  • Current Ratio: 1.02%
  • Quick Ratio: 0.67%
Additional Links:
Companies Related to Aegerion Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Aegerion Pharmaceuticals (NASDAQ:AEGR) (?)
Ratings Breakdown: 2 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $8.25 (341.18% upside)

Analysts' Ratings History for Aegerion Pharmaceuticals (NASDAQ:AEGR)
Show:
DateFirmActionRatingPrice TargetDetails
11/30/2016Cowen and CompanyReiterated RatingHold$1.50View Rating Details
11/11/2016J P Morgan Chase & CoInitiated CoverageHoldView Rating Details
5/17/2016Leerink SwannBoost Price TargetOutperform$6.00 -> $15.00View Rating Details
2/12/2016Bank of America CorporationDowngradeNeutral -> Underperform$6.00View Rating Details
12/21/2015GuggenheimUpgradeSell -> Buy$7.00 -> $13.00View Rating Details
11/10/2015Jefferies Group LLCLower Price TargetBuy$26.00 -> $16.00View Rating Details
5/26/2015Needham & Company LLCReiterated RatingHoldView Rating Details
(Data available from 2/19/2015 forward)

Earnings

Earnings History for Aegerion Pharmaceuticals (NASDAQ:AEGR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/10/2016        
5/16/2016Q1($0.58)($1.72)$43.00 million$35.70 millionViewListenView Earnings Details
2/25/2016Q4($0.89)($0.69)$47.74 million$49.00 millionViewListenView Earnings Details
11/9/2015Q315($0.42)($0.34)$59.72 million$67.30 millionViewN/AView Earnings Details
8/5/2015Q2($0.28)$0.23$58.98 million$64.20 millionViewN/AView Earnings Details
5/4/2015Q414($0.26)$0.06$59.30 millionViewN/AView Earnings Details
2/26/2015Q4$0.08$0.11$49.18 million$51.71 millionViewN/AView Earnings Details
10/30/2014Q314($0.14)($0.20)$48.60 million$43.70 millionViewN/AView Earnings Details
7/29/2014Q214($0.41)($0.33)$35.40 million$36.00 millionViewListenView Earnings Details
5/6/2014Q1($0.35)($0.25)$33.58 million$27.00 millionViewListenView Earnings Details
2/26/2014Q413($0.30)($0.14)$24.51 million$24.50 millionViewListenView Earnings Details
10/29/2013Q313($0.50)($0.43)$13.07 million$16.30 millionViewN/AView Earnings Details
7/30/2013Q2 2013($0.62)($0.66)$4.27 million$6.50 millionViewN/AView Earnings Details
11/7/2012Q312($0.56)($0.59)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Aegerion Pharmaceuticals (NASDAQ:AEGR)
Current Year EPS Consensus Estimate: $-3.10 EPS
Next Year EPS Consensus Estimate: $-0.43 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.77)$0.09($0.34)
Q2 20163($0.73)($0.01)($0.44)
Q3 20163($0.73)$0.15($0.37)
Q4 20163($0.78)($0.04)($0.42)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Aegerion Pharmaceuticals (NASDAQ:AEGR)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Aegerion Pharmaceuticals (NASDAQ:AEGR)
Insider Ownership Percentage: 4.60%
Institutional Ownership Percentage: 84.87%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/13/2016Healthcare Master Fun BroadfinMajor ShareholderBuy75,000$1.75$131,250.00View SEC Filing  
9/12/2016Healthcare Master Fun BroadfinMajor ShareholderBuy276,000$1.66$458,160.00View SEC Filing  
8/19/2014Mark J FitzpatrickCFOBuy1,150$30.64$35,236.00View SEC Filing  
7/31/2014Marc D BeerCEOBuy10,000$33.65$336,500.00View SEC Filing  
6/3/2014Marc D BeerCEOBuy10,000$30.12$301,200.00View SEC Filing  
5/27/2014Marc D BeerCEOBuy10,000$31.59$315,900.00View SEC Filing  
5/20/2014Marc BeerCEOBuy10,000$30.53$305,300.00View SEC Filing  
5/8/2014Anne VanlentDirectorBuy4,000$33.78$135,120.00View SEC Filing  
5/8/2014Marc BeerCEOBuy30,000$35.31$1,059,300.00View SEC Filing  
4/30/2014Craig FraserInsiderSell2,250$43.55$97,987.50View SEC Filing  
3/31/2014Craig FraserInsiderSell2,250$46.20$103,950.00View SEC Filing  
3/14/2014Mark SumerayInsiderSell2,000$51.34$102,680.00View SEC Filing  
2/11/2014Craig FraserInsiderSell2,250$67.00$150,750.00View SEC Filing  
12/16/2013Mark SumerayInsiderSell2,000$66.34$132,680.00View SEC Filing  
10/30/2013Marc D BeerCEOSell40,000$87.79$3,511,600.00View SEC Filing  
10/29/2013Sandford D SmithDirectorSell2,502$95.00$237,690.00View SEC Filing  
10/15/2013Mark SumerayInsiderSell2,000$80.33$160,660.00View SEC Filing  
10/7/2013Mark SumerayInsiderSell3,500$93.17$326,095.00View SEC Filing  
9/16/2013Mark SumerayInsiderSell2,000$89.77$179,540.00View SEC Filing  
9/5/2013Perceptive Advisors LlcMajor ShareholderSell750,000$89.20$66,900,000.00View SEC Filing  
8/21/2013David ScheerDirectorSell20,000$84.58$1,691,600.00View SEC Filing  
8/16/2013Mark SumerayInsiderSell2,000$88.71$177,420.00View SEC Filing  
8/15/2013Marc BeerCEOSell60,000$88.54$5,312,400.00View SEC Filing  
8/14/2013Mark FitzpatrickCFOSell7,500$93.44$700,800.00View SEC Filing  
8/12/2013Sandford SmithDirectorSell10,000$92.32$923,200.00View SEC Filing  
7/15/2013Mark SumerayInsiderSell2,000$78.77$157,540.00View SEC Filing  
6/17/2013Mark SumerayInsiderSell6,000$65.27$391,620.00View SEC Filing  
5/15/2013Mark SumerayInsiderSell6,000$47.32$283,920.00View SEC Filing  
2/1/2013Perceptive Advisors LlcMajor ShareholderBuy50,000$27.79$1,389,500.00View SEC Filing  
1/18/2013Perceptive Advisors LlcMajor ShareholderBuy50,000$27.62$1,381,000.00View SEC Filing  
1/17/2013Perceptive Advisors LlcMajor ShareholderBuy50,000$26.73$1,336,500.00View SEC Filing  
1/11/2013Perceptive Advisors LlcMajor ShareholderBuy475,000$27.07$12,858,250.00View SEC Filing  
12/4/2012Perceptive Advisors LlcMajor ShareholderBuy20,000$21.27$425,400.00View SEC Filing  
11/29/2012Perceptive Advisors LlcMajor ShareholderBuy30,000$22.71$681,300.00View SEC Filing  
11/28/2012Perceptive Advisors LlcMajor ShareholderBuy150,000$21.25$3,187,500.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Aegerion Pharmaceuticals (NASDAQ:AEGR)
DateHeadline
News IconEarnings Parade Rolls On, What Are Analysts Saying About Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR)? - Wall Street Beacon (NASDAQ:AEGR)
wsbeacon.com - February 1 at 3:26 PM
News IconEarnings in Full Force, Analysts Take Aim at Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) - Wall Street Beacon (NASDAQ:AEGR)
wsbeacon.com - January 25 at 3:25 PM
News IconValue Score Review for Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) - Liberty News (NASDAQ:AEGR)
libertynewsrecord.com - December 3 at 9:24 AM
News IconNarrowing in on the Numbers for Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) - Liberty News (NASDAQ:AEGR)
libertynewsrecord.com - December 1 at 3:20 PM
News IconVC Score Review for Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) - OIB News (NASDAQ:AEGR)
oibnews.com - December 1 at 3:20 PM
marketexclusive.com logoAEGERION PHARMACEUTICALS,INC. (NASDAQ:AEGR) Files An 8-K Entry into a Material Definitive Agreement (NASDAQ:AEGR)
marketexclusive.com - November 30 at 8:35 PM
News IconInside the Numbers for Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) - OIB News (NASDAQ:AEGR)
oibnews.com - November 30 at 10:12 AM
marketexclusive.com logoAEGERION PHARMACEUTICALS,INC. (NASDAQ:AEGR) Files An 8 ... - Market Exclusive (NASDAQ:AEGR)
marketexclusive.com - November 30 at 10:12 AM
biz.yahoo.com logoAEGERION PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Mater (NASDAQ:AEGR)
biz.yahoo.com - November 30 at 10:12 AM
feeds.reuters.com logoBRIEF-Aegerion Pharmaceuticals issues $325 mln aggregate principal amount of 2.00% convertible senior notes (NASDAQ:AEGR)
feeds.reuters.com - November 29 at 6:01 PM
News IconAegerion Pharmaceuticals and QLT Complete Merger Transaction; QLT to Change Name to Novelion Therapeutics (and Raises $22M) (NASDAQ:AEGR)
www.bctechnology.com - November 29 at 3:54 PM
News IconTrend Strength Monitor on Shares of Aegerion Pharmaceuticals Inc. (AEGR) - MicroCap Wired (NASDAQ:AEGR)
www.microcapwired.com - November 24 at 3:22 PM
News IconPenny Stock Spotlight: Focusing on Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) - Duncan Research (NASDAQ:AEGR)
www.duncanindependent.com - November 24 at 12:22 PM
News IconVC Score In Focus for Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) - Wall Street Lion (NASDAQ:AEGR)
wslnews.com - November 22 at 8:53 PM
News IconChart Watch: Following Indicators on Shares of Aegerion Pharmaceuticals Inc. (AEGR) - MicroCap Wired (NASDAQ:AEGR)
www.microcapwired.com - November 22 at 8:53 PM
News IconWonder Stock Alert: Investors Curious About Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) - Duncan Research (NASDAQ:AEGR)
www.duncanindependent.com - November 22 at 8:53 PM
News IconPenny Stock Making Waves: Investors Keen on Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) - Duncan Research (NASDAQ:AEGR)
www.duncanindependent.com - November 21 at 3:21 PM
streetinsider.com logoAegerion Pharma (AEGR) Receives Approval in Japan for JUXTAPID Pricing (NASDAQ:AEGR)
www.streetinsider.com - November 19 at 8:26 PM
News IconPenny Stock Focus: Narrowing the Lens On Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) - Duncan Research (NASDAQ:AEGR)
www.duncanindependent.com - November 18 at 3:22 PM
News IconTracking Technical Levels on Shares of Aegerion Pharmaceuticals Inc. (AEGR) - MicroCap Wired (NASDAQ:AEGR)
www.microcapwired.com - November 17 at 8:35 PM
News IconPenny Stock Making Waves: Taking a Second Look at Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) - Duncan Research (NASDAQ:AEGR)
www.duncanindependent.com - November 17 at 8:35 PM
streetinsider.com logoAegerion Pharma (AEGR) Receives Approval in Japan for JUXTAPID Pricing - StreetInsider.com (NASDAQ:AEGR)
www.streetinsider.com - November 17 at 8:35 PM
News IconMA in Focus for Aegerion Pharmaceuticals Inc. (AEGR) - MicroCap Wired (NASDAQ:AEGR)
www.microcapwired.com - November 15 at 9:34 PM
News IconThe Next Wonder Penny Stock? Investors Keen On Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) - Duncan Research (NASDAQ:AEGR)
www.duncanindependent.com - November 15 at 3:24 PM
News IconAegerion Pharmaceuticals, Inc. AEGR Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:AEGR)
www.bioportfolio.com - November 15 at 12:47 PM
News IconRange Watch on Technical Indicators for Aegerion Pharmaceuticals Inc. (AEGR) - MicroCap Wired (NASDAQ:AEGR)
www.microcapwired.com - November 14 at 12:46 PM
investornewswire.com logoCan Shares Of Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) Get To $1.5? - Investor Newswire (NASDAQ:AEGR)
www.investornewswire.com - November 12 at 8:27 PM
News IconAegerion Pharmaceuticals Inc. (AEGR) Earns Hold Rating from Analysts at JPMorgan Chase & Co. - Digital Cameras Planet Blog (blog) (NASDAQ:AEGR)
digital-cameras-planet.com - November 11 at 9:18 PM
News IconTraders are Keeping Track of Technicals on Shares of Aegerion Pharmaceuticals Inc. (AEGR) - MicroCap Wired (NASDAQ:AEGR)
www.microcapwired.com - November 11 at 3:22 PM
News IconPenny Stock News: Looking Closer At Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) - Duncan Research (NASDAQ:AEGR)
www.duncanindependent.com - November 11 at 3:22 PM
finance.yahoo.com logoAEGERION PHARMACEUTICALS, INC. Financials (NASDAQ:AEGR)
finance.yahoo.com - November 11 at 3:22 PM
News IconMA Watch on Shares of Aegerion Pharmaceuticals Inc. (AEGR) - MicroCap Wired (NASDAQ:AEGR)
www.microcapwired.com - November 10 at 9:20 PM
News IconPenny Stock Interest: Checking In On Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) - Duncan Research (NASDAQ:AEGR)
www.duncanindependent.com - November 10 at 9:20 PM
News IconAverage Directional Index Review for Aegerion Pharmaceuticals Inc. (AEGR) - MicroCap Wired (NASDAQ:AEGR)
www.microcapwired.com - November 8 at 1:44 PM
News IconPenny Stock Update: Traders Looking Closely at Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) - Duncan Research (NASDAQ:AEGR)
www.duncanindependent.com - November 8 at 1:44 PM
News IconAegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) Insider Trading Review - The Newburgh Press (NASDAQ:AEGR)
newburghpress.com - November 8 at 1:44 PM
capitalcube.com logoETF’s with exposure to Aegerion Pharmaceuticals, Inc. : November 8, 2016 (NASDAQ:AEGR)
www.capitalcube.com - November 8 at 1:44 PM
realistinvestor.com logoEPS Of $-0.5 Predicted For Aegerion Pharmaceuticals, Inc ... - RealistInvestor.com (NASDAQ:AEGR)
www.realistinvestor.com - November 7 at 9:49 PM
News IconAegerion Pharmaceuticals, Inc.'s (AEGR) Stock on the Run - - Hot Stocks Point (NASDAQ:AEGR)
www.hotstockspoint.com - November 7 at 9:49 PM
News IconNewsworthy Penny Stock: Zeroing In On Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) - Duncan Research (NASDAQ:AEGR)
www.duncanindependent.com - November 7 at 9:49 PM
biz.yahoo.com logoAEGERION PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (NASDAQ:AEGR)
biz.yahoo.com - November 7 at 9:49 PM
capitalcube.com logoAegerion Pharmaceuticals, Inc. :AEGR-US: Earnings Analysis: Q3, 2016 By the Numbers : November 7, 2016 (NASDAQ:AEGR)
www.capitalcube.com - November 7 at 1:06 PM
News IconShares Knocked Down Over Past Month: Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) - CSZ News (NASDAQ:AEGR)
cincysportszone.com - November 5 at 3:20 PM
News IconPenny Stock Update: Looking At Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) - Duncan Research (NASDAQ:AEGR)
www.duncanindependent.com - November 4 at 9:22 PM
zacks.com logoAegerion (AEGR) Reports Narrower-than-Expected Loss in Q3 (NASDAQ:AEGR)
www.zacks.com - November 4 at 3:16 PM
News IconPenny Stock in the News: Focusing In On Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) - Duncan Research (NASDAQ:AEGR)
www.duncanindependent.com - November 4 at 12:52 PM
nasdaq.com logoAegerion (AEGR) Reports Narrower-than-Expected Loss in Q3 - Nasdaq (NASDAQ:AEGR)
www.nasdaq.com - November 4 at 12:52 PM
globenewswire.com logoAegerion Pharmaceuticals Announces Third Quarter 2016 Financial ... - GlobeNewswire (press release) (NASDAQ:AEGR)
globenewswire.com - November 4 at 12:52 PM
News IconCCI Focus on Shares of Aegerion Pharmaceuticals Inc. (AEGR) - MicroCap Wired (NASDAQ:AEGR)
www.microcapwired.com - November 4 at 12:52 PM
einnews.com logoAegerion Pharmaceuticals Appoints John Orloff, M.D., as Executive Vice President, Head of R&D (NASDAQ:AEGR)
brazilbusiness.einnews.com - November 3 at 8:40 PM

Social

What is Aegerion Pharmaceuticals' stock symbol?

Aegerion Pharmaceuticals trades on the NASDAQ under the ticker symbol "AEGR."

Where is Aegerion Pharmaceuticals' stock going? Where will Aegerion Pharmaceuticals' stock price be in 2017?

3 analysts have issued 1 year target prices for Aegerion Pharmaceuticals' stock. Their predictions range from $1.50 to $15.00. On average, they expect Aegerion Pharmaceuticals' stock price to reach $8.25 in the next twelve months.

When will Aegerion Pharmaceuticals announce their earnings?

Aegerion Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Thursday, November, 10th 2016.

What are analysts saying about Aegerion Pharmaceuticals stock?

Here are some recent quotes from research analysts about Aegerion Pharmaceuticals stock:

  • Cowen and Company analysts commented, "Due to the November 29, 2016 merger of Aegerion Pharmaceuticals, Inc." (11/30/2016)

  • According to Zacks Investment Research, "Aegerion’s third-quarter results were encouraging, with the company reporting a narrower-than-expected loss and revenues surpassing expectations. Aegerion’s upcoming merger agreement with QLT Inc. is a big positive. It will leverage the company’s development and commercial capabilities to provide transformative treatments to patients suffering from rare but debilitating diseases. The agreement comes at a time when the company's lead drug, Juxtapid, is facing challenges due to the launch of PCSK9 inhibitors in the U.S. The company added another drug, Myalept from AstraZeneca, which boosted its portfolio. However, Aegerion is facing reimbursement hurdles for Myalept as prior authorizations are taking longer than expected and payers are requesting additional data. Moreover, the decision to withdraw Juxtapid from the EU is disappointing." (11/21/2016)

How do I buy Aegerion Pharmaceuticals stock?

Shares of Aegerion Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Aegerion Pharmaceuticals stock cost?

One share of Aegerion Pharmaceuticals stock can currently be purchased for approximately $1.87.

Aegerion Pharmaceuticals (NASDAQ:AEGR) Chart for Sunday, February, 19, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Aegerion Pharmaceuticals (NASDAQ:AEGR)

Earnings History Chart

Earnings by Quarter for Aegerion Pharmaceuticals (NASDAQ:AEGR)

Dividend History Chart

Dividend Payments by Quarter for Aegerion Pharmaceuticals (NASDAQ:AEGR)

Last Updated on 2/19/2017 by MarketBeat.com Staff